JL Steegmann, J Odriozola, F Rodriguez-Salvanes, P Giraldo, J Garcia-Larana, MT Ferro, E Benitez, C Perez-Pons, M Giralt, L Escribano, E Lavilla, A Miguel, C Areal, M Perez-Encinas, A Abad, J Maldonado, I Massague, JM Fernandez-Ranada. Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CML. haematol [Internet]. 1999Nov.1 [cited 2024May2];84(11):978-87. Available from: https://haematologica.org/article/view/1530